Moleculin Biotech Inc. (MBRX)

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028572 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Kiniksa Pharmaceuticals (KNSA)

Tessari Eben 🟡 adjusted position in 98.7K shares (3 derivative) of Kiniksa Pharmaceuticals International, plc (KNSA) at $35.66 ($6.6M) Transaction Date: Sep 04, 2025 | Filing ID: 023878

Vaxart Inc (VXRT)

New Form 8-K - Vaxart, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028570 Size: 186 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Veracyte Inc (VCYT)

Director Stapley Marc 🔴 sold 7.7K shares of VERACYTE, INC. (VCYT) at $30.41 Transaction Date: Sep 04, 2025 | Filing ID: 000124